262 related articles for article (PubMed ID: 20875732)
1. Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery.
Grabowski JP; Harter P; Buhrmann C; Lorenz D; Hils R; Kommoss S; Traut A; du Bois A
Surg Oncol; 2012 Mar; 21(1):31-5. PubMed ID: 20875732
[TBL] [Abstract][Full Text] [Related]
2. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
[TBL] [Abstract][Full Text] [Related]
3. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
5. Quality of care in advanced ovarian cancer: the importance of provider specialty.
Mercado C; Zingmond D; Karlan BY; Sekaris E; Gross J; Maggard-Gibbons M; Tomlinson JS; Ko CY
Gynecol Oncol; 2010 Apr; 117(1):18-22. PubMed ID: 20106512
[TBL] [Abstract][Full Text] [Related]
6. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.
Bristow RE; Palis BE; Chi DS; Cliby WA
Gynecol Oncol; 2010 Sep; 118(3):262-7. PubMed ID: 20573392
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of patients with apparent early-stage (FIGO I-II) epithelial ovarian cancer: a population-based study.
Petignat P; de Weck D; Goffin F; Vlastos G; Obrist R; Luthi JC
Gynecol Obstet Invest; 2007; 63(3):132-6. PubMed ID: 17057398
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Society of Gynecologic Oncologists (SGO) ovarian cancer quality surgical measures.
Gogoi RP; Urban R; Sun H; Goff B
Gynecol Oncol; 2012 Aug; 126(2):217-9. PubMed ID: 22561039
[TBL] [Abstract][Full Text] [Related]
9. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes.
Tozzi R; Köhler C; Ferrara A; Schneider A
Gynecol Oncol; 2004 Apr; 93(1):199-203. PubMed ID: 15047236
[TBL] [Abstract][Full Text] [Related]
11. The current status of surgical staging of ovarian serous borderline tumors.
Lin PS; Gershenson DM; Bevers MW; Lucas KR; Burke TW; Silva EG
Cancer; 1999 Feb; 85(4):905-11. PubMed ID: 10091769
[TBL] [Abstract][Full Text] [Related]
12. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
[TBL] [Abstract][Full Text] [Related]
13. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience.
Peiretti M; Zanagnolo V; Aletti GD; Bocciolone L; Colombo N; Landoni F; Minig L; Biffi R; Radice D; Maggioni A
Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma.
Soper JT; Johnson P; Johnson V; Berchuck A; Clarke-Pearson DL
Obstet Gynecol; 1992 Dec; 80(6):949-53. PubMed ID: 1333065
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic surgical staging in cervical cancer--preliminary experience among Chinese.
Chu KK; Chang SD; Chen FP; Soong YK
Gynecol Oncol; 1997 Jan; 64(1):49-53. PubMed ID: 8995546
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
17. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
[TBL] [Abstract][Full Text] [Related]
18. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.
Aletti GD; Santillan A; Eisenhauer EL; Hu J; Aletti G; Podratz KC; Bristow RE; Chi DS; Cliby WA
Gynecol Oncol; 2007 Oct; 107(1):99-106. PubMed ID: 17602726
[TBL] [Abstract][Full Text] [Related]
19. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
Soegaard Andersen E; Knudsen A; Svarrer T; Lund B; Nielsen K; Grove A; Tetsche M
Gynecol Oncol; 2005 Dec; 99(3):552-6. PubMed ID: 16150480
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic spread among women with primary peritoneal carcinoma.
Eltabbakh GH; Mount SL
J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
